In fact, increased ANPEP expression is a hallmark of inflammation in neurodegenerative disease, and impaired ANPEP activity has been investigated as a target for anti-inflammatory therapy (87, 88). The gene discussed is ANPEP; the disease is neurodegenerative disease.